These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17498116)

  • 1. Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis.
    Van Eps CL; Jeffries JK; Anderson JA; Bergin PT; Johnson DW; Campbell SB; Carpenter SM; Isbel NM; Mudge DW; Hawley CM
    Nephrology (Carlton); 2007 Jun; 12(3):224-33. PubMed ID: 17498116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis.
    Kim SJ; Goldstein M; Szabo T; Pierratos A
    Am J Kidney Dis; 2003 Mar; 41(3):E12. PubMed ID: 12613005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium and phosphate balance in adolescents on home nocturnal haemodialysis.
    Hothi DK; Harvey E; Piva E; Keating L; Secker D; Geary DF
    Pediatr Nephrol; 2006 Jun; 21(6):835-41. PubMed ID: 16583243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial.
    Walsh M; Manns BJ; Klarenbach S; Tonelli M; Hemmelgarn B; Culleton B
    Hemodial Int; 2010 Apr; 14(2):174-81. PubMed ID: 20041960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of biochemical, haematological and volume parameters in two treatment schedules of nocturnal home haemodialysis.
    Mahadevan K; Pellicano R; Reid A; Kerr P; Polkinghorne K; Agar J
    Nephrology (Carlton); 2006 Oct; 11(5):413-8. PubMed ID: 17014555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients.
    Laowalert S; Khotavivattana T; Wattanachanya L; Luangjarmekorn P; Udomkarnjananun S; Katavetin P; Eiam-Ong S; Praditpornsilpa K; Susantitaphong P
    Nephrology (Carlton); 2020 Feb; 25(2):163-171. PubMed ID: 30980579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S; Brandi L; Olgaard K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis.
    Toussaint N; Boddington J; Simmonds R; Waldron C; Somerville C; Agar J
    Hemodial Int; 2006 Jul; 10(3):280-6. PubMed ID: 16805890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
    Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients.
    Johnson DW; Rigby RJ; McIntyre HD; Brown A; Freeman J
    Nephrol Dial Transplant; 1996 Jan; 11(1):88-93. PubMed ID: 8649658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
    Spasovski G; Gelev S; Masin-Spasovska J; Selim G; Sikole A; Vanholder R
    Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM; Thomas J; Clewes A; Hopkins MT; Guzder R; Ibrahim H; Durham BH; Vora JP; Fraser WD
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of progressive vascular calcification in haemodialysis patients.
    Chertow GM; Raggi P; Chasan-Taber S; Bommer J; Holzer H; Burke SK
    Nephrol Dial Transplant; 2004 Jun; 19(6):1489-96. PubMed ID: 15102961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density.
    Asmus HG; Braun J; Krause R; Brunkhorst R; Holzer H; Schulz W; Neumayer HH; Raggi P; Bommer J
    Nephrol Dial Transplant; 2005 Aug; 20(8):1653-61. PubMed ID: 15930018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
    Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
    J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis.
    van Eps C; Hawley C; Jeffries J; Johnson DW; Campbell S; Isbel N; Mudge DW; Prins J
    Nephrology (Carlton); 2012 Jan; 17(1):42-7. PubMed ID: 21914037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.